United chairman tells AGM of plans for 2007

ISEQ-listed United Drug’s chairman was upbeat when addressing today’s AGM.

Ronnie Kells spoke of the company’s plans for the year ahead and told investors: “I am pleased to report that United Drug has made a good start to the year with profits in the first quarter ahead of the same period last year.

“In March the first phase of the Irish Government review of the drug-pricing agreement will take effect with a reduction in the price of off-patent branded medicines. We have robust plans in place to manage this process.

“Our new acquisitions are performing ahead of expectations and we expect to make further progress during the year with our strategy of developing United Drug into a broadly-based healthcare-services group.

“Against this background we look forward to another successful year of growth.”